US 11185592
Spirocyclic degronimers for target protein degradation
granted A61KA61K31/435A61K31/438
Quick answer
US patent 11185592 (Spirocyclic degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K47/545, A61K47/554